240 families worried about their child’s health are asking for compensation. In September 2014, defective batches of vaccine against the meningitis C, Meningitec, had raised serious concerns. Heavy metals had indeed been detected in some of the syringes on the market. 21 lots had thus been withdrawn from sale. One year later, the lawsuit against the distributor of this vaccine, the CSP laboratory (Center Spécialités Pharmaceutiques) opens in Clermont-Ferrand. This laboratory is accused of having delayed in removing the defective batches of vaccines despite the alert launched by the health authorities, continuing to contaminate young children.
The hearing began on September 22, 2015 and the trial promises to be long. The CSP laboratory has in fact requested health expertise on the children of families complaining, to look for suspected traces of heavy metals. Initial analyzes on the hair of the children concerned had already proved the presence of lead, aluminum, tin, silver and silicon. In addition, within a year, symptoms such as fevers, vomiting, diarrhea, rashes, irritability and sleep disturbances were observed in the young children concerned. But for the moment, no proof that the vaccine is really responsible for these manifestations has been provided. In addition, pharmacies and health authorities could also be concerned during this trial.
In France, vaccination against meningitis C is not compulsory but remains strongly recommended for infants aged 12 months, with a possible extension up to the age of 24 years. Meningococci C can cause meningitis and sepsis, bacterial infections that can be fatal.
>> To read also:
Compulsory vaccination of children is constitutional
Is your teen up to date on his vaccines?
Vaccines: general practitioners less and less confident
Petition from Prof. Joyeux about the DT-Polio vaccine: beware of the arguments put forward
Heavy metals in “vintage” toys
